Strata Critical Medical, Inc.
SRTA
$5.03
-$0.06-1.18%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 30.37% | -0.09% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 30.37% | -0.09% | |||
| Cost of Revenue | 25.36% | 1.34% | |||
| Gross Profit | 48.08% | -4.85% | |||
| SG&A Expenses | 16.14% | -0.15% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 22.40% | 0.98% | |||
| Operating Income | 34.67% | -9.41% | |||
| Income Before Tax | -6.04% | 64.54% | |||
| Income Tax Expenses | 223.53% | 83.81% | |||
| Earnings from Continuing Operations | -7.16% | 64.33% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -7.16% | 64.33% | |||
| EBIT | 34.67% | -9.41% | |||
| EBITDA | 46.01% | -8.98% | |||
| EPS Basic | -5.26% | 64.96% | |||
| Normalized Basic EPS | -4.00% | 59.14% | |||
| EPS Diluted | -14.42% | 64.96% | |||
| Normalized Diluted EPS | -4.00% | 59.14% | |||
| Average Basic Shares Outstanding | 1.76% | 1.72% | |||
| Average Diluted Shares Outstanding | 1.76% | 1.72% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||